Article Details
Retrieved on: 2024-01-23 20:42:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
NGM Biopharmaceuticals, Inc. was notified by Nasdaq on January 18, 2024, that it has regained compliance with the minimum bid price requirement ...
Article found on: www.tipranks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here